Suministro de la asociación de Pertuzumab (DOE) y Trastuzumab (DOE), Emicizumab (DOE), Faricimab (DOE), Glofitamab (DOE), Obinutuzumab (DOE) y Trastuzumab emtansina (DOE)
Deadline:N/A
Contract award
Estimated value
€122,512,491.18
Duration
5 years
Bidders
Awarded bidders
Name
ROCHE FARMA, S.A. UNIPERSONAL
